UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025831 |
|---|---|
| Receipt number | R000029525 |
| Scientific Title | High-dose clarithromycin monotherapy for Helicobacter pylori-negative or -eradicated gastrointestinal MALT lymphomas |
| Date of disclosure of the study information | 2017/01/25 |
| Last modified on | 2019/03/20 08:24:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/24 21:48:37 | ||
| 2 | Update | 2017/01/25 08:28:25 | Date of disclosure of the study information |
|
| 3 | Update | 2017/07/25 13:59:45 | Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2017/07/25 14:06:21 | Recruitment status Anticipated trial start date |
|
| 5 | Update | 2018/01/27 13:37:26 | Trial characteristics_1 Trial characteristics_2 Developmental phase |
|
| 6 | Update | 2018/01/27 13:45:27 | Co-sponsor Co-sponsor Institutions |
|
| 7 | Update | 2019/01/26 13:50:04 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results |
|
| 8 | Update | 2019/02/27 17:54:48 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results |
|
| 9 | Update | 2019/02/28 18:11:55 | Results |
|
| 10 | Update | 2019/03/19 13:04:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Co-sponsor Organization Organization Address Address Tel |
|
| 11 | Update | 2019/03/19 19:18:45 | Recruitment status Date of IRB |
|
| 12 | Update | 2019/03/20 08:24:52 | URL related to results and publications Number of participants that the trial has enrolled Adverse events |
